Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +1.06% | +2.41% |
2020 | Mark Corrigan Departs as CEO from Correvio Pharma Corp | CI |
2020 | Justin Renz, CFO Departs from Correvio Pharma Corp | CI |
Financials (USD)
Sales 2018 | 28.67M | Sales 2019 | 32.63M | Capitalization | 27.28M |
---|---|---|---|---|---|
Net income 2018 | -16M | Net income 2019 | -35M | EV / Sales 2018 | 5.13 x |
Net Debt 2018 | 25.92M | Net Debt 2019 | 33.9M | EV / Sales 2019 | 1.87 x |
P/E ratio 2018 |
-7.1
x | P/E ratio 2019 |
-0.68
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 86.23% |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- CORV Stock
- CORV Stock